News
Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that President and co-CEO Sam Lee, PhD discussed the scientific foundation ...
There are currently no approved vaccines or treatments for norovirus infectionCocrystal’s CDI-988 is the first antiviral for the potential ...
1d
TipRanks on MSNCocrystal Pharma Advances CDI-988 to Phase 1b Study
Cocrystal Pharma ( ($COCP) ) has issued an update. Cocrystal Pharma announced that its President and co-CEO, Dr. Sam Lee, presented the company’s ...
Qiagen N.V. ( NYSE: QGEN) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 1:05 PM EDT ...
4d
Clinical Trials Arena on MSNCocrystal Pharma’s norovirus antiviral study receives FDA clearance
C ocrystal Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to ...
3d
New Scientist on MSNAntibody cocktail could work as a universal flu treatment
A mix of three antibodies seems to protect mice against several strains of influenza and could one day be useful against ...
Endoscopic sinus surgery for chronic rhinosinusitis (CRS) provides significantly better disease-specific quality of life at 6 ...
Although apple cider vinegar has benefits, there are also potential side effects to consider. The high acidity can strip ...
WHEN Zara Cheesman fell ill with a “vomiting bug”, paramedics acknowledged she was “clearly a very ill child”, but advised ...
Nordisk and Eli Lilly are set to reshape the oral GLP-1 market as patient demand grows and new therapies emerge. Learn more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results